Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance

Br J Dermatol. 2019 Apr;180(4):949. doi: 10.1111/bjd.17423. Epub 2019 Jan 1.

Authors

C Marasca¹, A Masarà¹, M C Annunziata¹, V Bettoli², M A Luciano¹, G Fabbrocini¹

Affiliations

¹ Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via Pansini 5, Napoli, Italy.
² Section of Dermatology, Department of Medical Sciences, University of Ferrara, Arcispedale S. Anna, Ferrara, Italy.

PMID: 30430549
DOI: 10.1111/bjd.17423

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Clindamycin*
Drug Therapy, Combination
Hidradenitis Suppurativa*
Humans
Rifampin

Substances

Anti-Bacterial Agents
Clindamycin
Rifampin